| Application no. and date | 10178595.4 (espacenet) (Federated) (European Patent Register), 20010117 | | Patent/reg. no. and date | DK/EP 2289545, 20160608 | | Publication date | 20110302 | | Priority no. and date | GB 0001067, 20000117, GB 0005699, 20000309 | | EP pub. no. and date |
EP 2289545 20110302 | | Effective date | | | Applicant/owner | GlaxoSmithKline Biologicals SA, Rue de l'Institut 89
1330 Rixensart, BE | | Applicant ref. no. | 159865 | | Inventor | RAPPUOLI, Rino, Novartis Vaccines
Via Fiorentina, 1
I-53100 Siena, IT,
Pizza, Mariagrazia, Novartis Vaccines
Via Fiorentina 1
53100 Siena, IT,
Giuliani, Marzia, Novartis Vaccines
Via Fiorentina 1
53100 Siena, IT | | Representative | AWA Denmark A/S, Strandgade 56, 1401 København K, DK | | Opponent | | | IPC Class | A61K 39/00 (2006.01) , A61K 39/095 (2006.01) , A61K 39/116 (2006.01) , A61K 39/295 (2006.01) , A61P 31/00 (2006.01) | | Title | Suppleret OMV-vaccine mod meningococcus | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
